Exploring gene editing in clinical trials

I’ve been diving into the recent advances in CRISPR technology and its applications in clinical settings. It’s fascinating how gene editing can potentially correct genetic disorders before they manifest. I’m curious if anyone here has experience with designing studies that assess the long-term effects of such interventions. Any insights or recent literature that you could recommend would be greatly appreciated.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​‍‌‍‍‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌⁠​⁠​‌​⁠​‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠‌‍‌‍‌‌‌⁠‌‌‌‍​‍‌​‍‌‌​‍​‌​​⁠‌‌​⁠​⁠​​​⁠​‍‌‌​⁠​‍⁠‌‌‌‌⁠‌‌​‌‌​‍‍​⁠​​​‍​‍‌⁠⁠‌​